However, recent evidence in these tissues and others like heart and kidney (208, 209) highlights controversy and indicates that inactivating FoxO1 could either mitigate or exacerbate T2D pathology (2–5). The gene discussed is FOXO1; the disease is type 2 diabetes mellitus.